HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (33) Citing Articles via Google Scholar Google Scholar Articles by Hare, W. A. Articles by Wheeler, L. Search for Related Content PubMed PubMed Citation Articles by Hare, W. A. Articles by Wheeler, L.

Efficacy and Safety of Memantine Treatment for Reduction of Changes Associated with Experimental Glaucoma in Monkey, II: Structural Measures

¹From the Department of Biological Sciences, Allergan Inc., Irvine, California; and ²Hamilton Glaucoma Center, University of California, San Diego, La Jolla, California.

PURPOSE. To determine, using anatomic measurements, whether daily oral dosing with memantine is both safe and effective to reduce the injury associated with experimental glaucoma in primates.

METHODS. Argon laser treatment of the anterior chamber angle was used to induce chronic ocular hypertension (COHT) in the right eyes of 18 macaque monkeys. Nine animals were daily orally dosed with 4 mg/kg memantine while the other nine animals received vehicle only. Measurements of intraocular pressure (IOP) from both eyes of all animals were made at regular intervals. Appearance of the optic nerve head, retinal vessels, and surrounding retina was documented with stereo fundus photographs obtained at multiple time points throughout the study. Measurements of optic nerve head topography were obtained from confocal laser scans made from animals with the highest IOPs at approximately 3, 5, and 10 months after elevation of IOP. At approximately 16 months after IOP elevation, animals were killed and histologic counts of cells in the retinal ganglion cell (RGC) layer were made.

RESULTS. Histologic measurements showed that, for animals with moderate elevation of IOP, memantine treatment was associated with an enhanced survival of RGCs in the inferior retina. Measurements of optic nerve head topography showed less IOP-induced change in memantine-treated animals. This effect was seen in measurements of both the cup and the neuroretinal rim. A comparison of these same histologic and morphologic measurements in normotensive eyes from the two treatment groups showed that memantine treatment was not associated with any significant effects on these eyes.

CONCLUSIONS. Histologic measurements of RGC survival as well as tomographic measurements of nerve head topography show that systemic treatment with memantine, a compound which does not lower intraocular pressure, is both safe and effective to reduce changes associated with experimental glaucoma.

This article has been cited by other articles:

				D J Holcombe, N Lengefeld, G A Gole, and N L Barnett Selective inner retinal dysfunction precedes ganglion cell loss in a mouse glaucoma model Br. J. Ophthalmol., May 1, 2008; 92(5): 683 - 688. [Abstract] [Full Text] [PDF]

				J. Kusari, S. Zhou, E. Padillo, K. G. Clarke, and D. W. Gil Effect of Memantine on Neuroretinal Function and Retinal Vascular Changes of Streptozotocin-Induced Diabetic Rats Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5152 - 5159. [Abstract] [Full Text] [PDF]

				W. Fan, X. Li, and N. G. F. Cooper CaMKII{alpha}B Mediates a Survival Response in Retinal Ganglion Cells Subjected to a Glutamate Stimulus Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3854 - 3863. [Abstract] [Full Text] [PDF]

				R. K. P. Sullivan, E. WoldeMussie, L. Macnab, G. Ruiz, and D. V. Pow Evoked Expression of the Glutamate Transporter GLT-1c in Retinal Ganglion Cells in Human Glaucoma and in a Rat Model. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3853 - 3859. [Abstract] [Full Text] [PDF]

				L. Guo, T. E. Salt, A. Maass, V. Luong, S. E. Moss, F. W. Fitzke, and M. F. Cordeiro Assessment of Neuroprotective Effects of Glutamate Modulation on Glaucoma-Related Retinal Ganglion Cell Apoptosis In Vivo Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 626 - 633. [Abstract] [Full Text] [PDF]

				Y. H. Yucel, N. Gupta, Q. Zhang, A. P. Mizisin, M. W. Kalichman, and R. N. Weinreb Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch Ophthalmol, February 1, 2006; 124(2): 217 - 225. [Abstract] [Full Text] [PDF]

				T Taniguchi, M Shimazawa, M Araie, G Tomita, M Sasaoka, Y Kitazawa, and H Hara Optic disc topographic parameters measured in the normal cynomolgus monkey by confocal scanning laser tomography Br. J. Ophthalmol., August 1, 2005; 89(8): 1058 - 1062. [Abstract] [Full Text] [PDF]

				W. A. Hare, E. WoldeMussie, R. K. Lai, H. Ton, G. Ruiz, T. Chun, and L. Wheeler Efficacy and Safety of Memantine Treatment for Reduction of Changes Associated with Experimental Glaucoma in Monkey, I: Functional Measures Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2625 - 2639. [Abstract] [Full Text] [PDF]